on April 25, 2018
The Louis-Jeantet Foundation, during a ceremony hold on Wednesday April 25th at the Centre Médical Universitaire (CMU) in Geneva, conferred the 2018 Louis-Jeantet Prize for Medicine to Antonio Lanzavecchia, Director of the Institute for Research in Biomedicine in Bellinzona and Professor of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) and to Christer Betsholtz, Director of the Cardio-Metabolic Center integrated at the Karolinska Institutet and Professor at the Uppsala University.
 |
 |
| Prof. Lanzavecchia receiving the 2018 Louis-Jeantet Prize for Medicine from Sir Paul Nurse, The Francis Crick Institute, London (© Les Studios Casagrande) | Prof. Lanzavecchia (© Les Studios Casagrande) |
Every year, the Louis-Jeantet Foundation awards leading researchers working in countries that are members of the European Council. Recognized as one of the most prestigious of the Old Continent, the Louis-Jeantet Prize for Medicine – worth 700.000 Swiss francs – promotes scientific excellence applied to innovative research projects with high added value.
Prof. Lanzavecchia has been awarded for his findings on the human immune response and their possible applications in the development of new vaccines and antibody-based therapies. The prize amount will be allocated to continue his research on the new antibody diversification mechanism.
Founded in 1986, the Louis-Jeantet Prize for Medicine has, so far, been awarded to 88 researchers, from whom 16 in Switzerland. Among the award-winners, 10 were subsequently distinguished by the Nobel Prizes in Physiology, Medicine or Chemistry. Since 1986, the Foundation has allocated a total sum of over 60 million francs.
Video: https://www.jeantet.ch/prix-louis-jeantet/laureats/2018/antonio-lanzavecchia/
